Marinescu et al. [39] analyzed how age, comorbidities, polytherapies, and other factors affect BNP/NTproBNP levels in geriatric patients (without cognitive impairment) and how this affects the specificity and sensitivity of these biomarkers in identifying heart failure in this category of patients. Here, NPPB is linked to heart failure.